You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Haploidentical Donors

Showing 1 - 25 of 1,549
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

Recruiting
  • Hematologic Malignancy
  • CD45RA depleted donor lymphocyte infusion (DLI)
  • Tuebingen,, Germany
  • +1 more
Jul 13, 2023

Haplo-identical Transplantation, Transplantation Trial in Paris (Evaluate the evolution of the psychic state of the donors

Not yet recruiting
  • Haplo-identical Transplantation
  • Transplantation
  • Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft.
  • Paris, France
    Service D'hématologie Clinique et thérapie cellulaire - Hôpital
Oct 17, 2023

Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

Recruiting
  • Hemoglobinopathy (Disorder)
  • +2 more
  • Haploidentical Hematopoietic Cell Transplantation
  • Saint Petersburg, Florida
    Johns Hopkins All Children's Hospital
Sep 13, 2022

Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using

Recruiting
  • Relapsed Pediatric ALL
  • +2 more
  • In Vitro T cells depletion using CliniMCAS system
  • Shanghai, China
    Shanghai Children's Medical Center
Sep 28, 2022

Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)

Recruiting
  • Hematologic Neoplasms
  • Milan, Italy
    European Institute of Oncology
Sep 24, 2021

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Hematologic Malignancy, Haplo-identical Stem Cell Transplantation Trial (CD45RAneg cells, prepared from mononuclear cell

Not yet recruiting
  • Hematologic Malignancy
  • Haplo-identical Stem Cell Transplantation
  • CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology
  • (no location specified)
Oct 1, 2021

Lymphoma Trial in Madison (drug, radiation, biological, procedure)

Completed
Has Results
  • Lymphoma
  • Fludarabine Phosphate
  • +9 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 7, 2021

Primary Immune Deficiency Disorders, Metabolic Disease Trial in Saint Petersburg (Haploidentical Hematopoietic Cell

Recruiting
  • Primary Immune Deficiency Disorders
  • Metabolic Disease
  • Haploidentical Hematopoietic Cell Transplantation
  • Saint Petersburg, Florida
    Johns Hopkins All Children's Hospital
Sep 9, 2021

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
Apr 4, 2022

Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)

Recruiting
  • Sickle Cell Disease
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Feb 17, 2023

Primary Immune Deficiency Disorder, Hematopoietic Stem Cell Transplantation Trial in Moscow (Biological: TCR alfa beta T cell

Completed
Has Results
  • Primary Immune Deficiency Disorder
  • Hematopoietic Stem Cell Transplantation
  • Biological: TCR alfa beta T cell depletion
  • Moscow, Russian Federation
    Dmitry Rogachev Federal Research and Clinical Centre of Paediatr
Feb 9, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 6, 2022

Sickle Cell Disease Trial in Chicago (aß+ T-cell depletion with Miltenyi CliniMACS system)

Recruiting
  • Sickle Cell Disease
  • αβ+ T-cell depletion with Miltenyi CliniMACS system
  • Chicago, Illinois
    The University of Chicago
May 13, 2022

Acute Myeloid Leukemia Trial in Bayreuth, Chemnitz, Dresden (NK cells, Cytarabine)

Terminated
  • Acute Myeloid Leukemia
  • Bayreuth, Germany
  • +2 more
Aug 10, 2021

Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

Available
  • Benign Neoplasm
  • +3 more
  • Bone Marrow Transplantation
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 9, 2021

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

Hematopoietic Stem Cell Transplantation Trial in Beijing (post-transplantation cyclophosphamide)

Completed
  • Hematopoietic Stem Cell Transplantation
  • post-transplantation cyclophosphamide
  • Beijing, China
    Peking University People's Hospital
Sep 15, 2020

Acute Leukemia Trial in Italy (allogeneic transplant)

Completed
  • Acute Leukemia
  • allogeneic transplant
  • Alessandria, Italy
  • +29 more
Aug 19, 2021

Leukemia Trial in China (Cytarabine, Busulfan, Cyclophosphamide)

Recruiting
  • Leukemia
  • Hangzhou, China
  • +7 more
Sep 15, 2020

Acute Myeloid Leukemia Trial in Seoul (Transplants from 8/8-matched Unrelated donors, Transplants from

Unknown status
  • Acute Myeloid Leukemia
  • Transplants from 8/8-matched Unrelated donors
  • Transplants from family-mismatched/haploidentical donors
  • Seoul, Korea, Republic of
    Catholic Blood and Marrow Transplantation Center, Seoul St. Mary
Sep 17, 2019

Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

Completed
Has Results
  • Blood Cancer
  • +7 more
  • non-myeloablative hematopoietic cell transplantation
  • +8 more
  • Stanford, California
    Stanford University School of Medicine
Nov 17, 2019

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
Has Results
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

Not yet recruiting
  • Sickle Cell Disease
  • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023